Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention | Zendy

Konstantinos Spargias | Zendy; Elias Adreanides | Zendy; Eftychia Demerouti | Zendy; Aggeliki Gkouziouta | Zendy; Athanassios Manginas | Zendy; Gregory Pavlides | Zendy; Vassilis Voudris | Zendy; Dennis V. Cokkinos | Zendy

Open Access

Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention

Author(s) -

Konstantinos Spargias,

Elias Adreanides,

Eftychia Demerouti,

Aggeliki Gkouziouta,

Athanassios Manginas,

Gregory Pavlides,

Vassilis Voudris,

Dennis V. Cokkinos

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.863159

Subject(s) - medicine , contrast induced nephropathy , coronary angiography , nephropathy , cardiology , angiography , iloprost , percutaneous coronary intervention , myocardial infarction , diabetes mellitus , endocrinology , prostacyclin

The prevention of contrast-induced nephropathy, which accounts for considerable morbidity and mortality, remains a vexing problem. Contrast-induced renal vasoconstriction is believed to play a pivotal role in the pathogenesis of contrast-induced nephropathy. The aim of this study was to examine the efficacy of the prostacyclin analog iloprost in preventing contrast-induced nephropathy in patients with renal dysfunction undergoing a coronary procedure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research